Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.990
+0.010 (0.20%)
Feb 27, 2026, 4:00 PM EST - Market closed
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $58.07 million as of February 27, 2026. Its market cap has increased by 57.96% in one year.
Market Cap
58.07M
Enterprise Value
32.17M
1-Year Change
57.96%
Ranking
Category
Stock Price
$4.99
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $58.07M, a decrease of -20.28%. That is a compound annual growth rate of -5.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 58.07M | -1.74% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 61.98M |
| Instil Bio | 60.36M |
| TScan Therapeutics | 60.15M |
| ImmuCell | 59.43M |
| NRx Pharmaceuticals | 59.28M |
| Mereo BioPharma Group | 58.97M |
| Spruce Biosciences | 58.81M |
| Metagenomi Therapeutics | 57.07M |